Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Lindemann

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Plos One|May 27, 2016
MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine EvaluationElizabeth R Allen, Pauline van Diemen, Yuko Yamaguchi, et al.
Scientific Reports|November 24, 2015
The activity of protein phosphatase 5 towards native clients is modulated by the middle- and C-terminal domains of Hsp90Veronika Haslbeck, Julia M Eckl, Adrian Drazic, et al.
BMJ Open|June 4, 2016
Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort studyAmy Flaxman, Elizabeth Allen, Claudia Lindemann, et al.
Vaccines|February 28, 2023
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA VaccinesCynthia M Rohde, Claudia Lindemann, Michael Giovanelli, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 31, 2021
Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccineChristopher J Bowman, Marie Bouressam, Sarah N Campion, et al.
Vaccine|August 28, 2024
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccineShanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
Science Translational Medicine|May 22, 2024
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6Christiane R Stadler, Ursula Ellinghaus, Leyla Fischer, et al.
Iscience|June 22, 2026
Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activitySven Kratochvil, Maximilian Kullmann, Henning Gruell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2016
Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formationSudip Das, Claudia Lindemann, Bernadette C Young, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Plos One|May 27, 2016
MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine EvaluationElizabeth R Allen, Pauline van Diemen, Yuko Yamaguchi, et al.
Scientific Reports|November 24, 2015
The activity of protein phosphatase 5 towards native clients is modulated by the middle- and C-terminal domains of Hsp90Veronika Haslbeck, Julia M Eckl, Adrian Drazic, et al.
BMJ Open|June 4, 2016
Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort studyAmy Flaxman, Elizabeth Allen, Claudia Lindemann, et al.
Vaccines|February 28, 2023
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA VaccinesCynthia M Rohde, Claudia Lindemann, Michael Giovanelli, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 31, 2021
Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccineChristopher J Bowman, Marie Bouressam, Sarah N Campion, et al.
Vaccine|August 28, 2024
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccineShanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.
Oncoimmunology|October 20, 2023
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyHayat Bähr-Mahmud, Ursula Ellinghaus, Christiane R Stadler, et al.
Science Translational Medicine|May 22, 2024
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6Christiane R Stadler, Ursula Ellinghaus, Leyla Fischer, et al.
Iscience|June 22, 2026
Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activitySven Kratochvil, Maximilian Kullmann, Henning Gruell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2016
Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formationSudip Das, Claudia Lindemann, Bernadette C Young, et al.
Pageof 3